JETEMA, Co., Ltd. (KOSDAQ:216080)
5,450.00
-170.00 (-3.02%)
May 20, 2026, 3:30 PM KST
JETEMA, Market Cap
JETEMA, has a market cap or net worth of 202.79 billion as of May 20, 2026. Its market cap has decreased by -24.06% in one year.
Market Cap
202.79B
Enterprise Value
314.88B
Revenue
76.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,450.00
Market Cap Chart
Since November 14, 2019, JETEMA,'s market cap has increased from 129.11B to 202.79B, an increase of 57.07%. That is a compound annual growth rate of 7.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 202.79B | -7.98% |
| Dec 30, 2025 | 220.37B | -20.54% |
| Dec 30, 2024 | 277.33B | -0.13% |
| Dec 28, 2023 | 277.70B | 19.01% |
| Dec 29, 2022 | 233.35B | -35.77% |
| Dec 30, 2021 | 363.31B | -9.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anterogen.Co.,Ltd. | 316.69B |
| GC Cell | 297.09B |
| BINEX | 287.90B |
| HLB Therapeutics | 270.75B |
| Bioneer | 259.39B |
| NeoImmuneTech | 247.66B |
| EASY BIO,Inc. | 231.90B |
| Genexine | 186.47B |